⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CRMD News
CorMedix Inc.
Form 8-K
sec.gov
CRMD
Cormedix Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Update
globenewswire.com
CRMD
Form 8-K
sec.gov
CRMD
HRTX
Form 8-K
sec.gov
CRMD
CorMedix Therapeutics to Acquire Substantially All Assets of Heron Therapeutics, Expanding Its Portfolio of Products Used in Institutional Settings of Care
globenewswire.com
CRMD
HRTX
CorMedix Therapeutics to Acquire Substantially All Assets of Heron Therapeutics, Expanding Its Portfolio of Products Used in Institutional Settings of Care
globenewswire.com
CRMD
HRTX
CorMedix Therapeutics to Report Third Quarter 2026 Financial Results and Provide a Corporate Update on November 12, 2026
globenewswire.com
CRMD
Form 8-K
sec.gov
CRMD
CorMedix Therapeutics Provides Business Update, Reaffirms 2026 Total Revenue Guidance, and Reports Third Quarter Cash Position
globenewswire.com
CRMD
Form 8-K
sec.gov
CRMD